IT1164633B - 3,4-diammino-1,2,5-tiadiazoli dotati di attivita' antagonista dei recettori istaminici - Google Patents

3,4-diammino-1,2,5-tiadiazoli dotati di attivita' antagonista dei recettori istaminici

Info

Publication number
IT1164633B
IT1164633B IT48005/83A IT4800583A IT1164633B IT 1164633 B IT1164633 B IT 1164633B IT 48005/83 A IT48005/83 A IT 48005/83A IT 4800583 A IT4800583 A IT 4800583A IT 1164633 B IT1164633 B IT 1164633B
Authority
IT
Italy
Prior art keywords
tiadiazoli
diammino
antagonist activity
histamine receptors
histamine
Prior art date
Application number
IT48005/83A
Other languages
English (en)
Other versions
IT8348005A0 (it
Inventor
Ronnie Ray Crenshaw
Aldo Antonio Algieri
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of IT8348005A0 publication Critical patent/IT8348005A0/it
Application granted granted Critical
Publication of IT1164633B publication Critical patent/IT1164633B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/06—1,2,3-Thiadiazoles; Hydrogenated 1,2,3-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IT48005/83A 1982-03-29 1983-03-28 3,4-diammino-1,2,5-tiadiazoli dotati di attivita' antagonista dei recettori istaminici IT1164633B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36320782A 1982-03-29 1982-03-29

Publications (2)

Publication Number Publication Date
IT8348005A0 IT8348005A0 (it) 1983-03-28
IT1164633B true IT1164633B (it) 1987-04-15

Family

ID=23429274

Family Applications (1)

Application Number Title Priority Date Filing Date
IT48005/83A IT1164633B (it) 1982-03-29 1983-03-28 3,4-diammino-1,2,5-tiadiazoli dotati di attivita' antagonista dei recettori istaminici

Country Status (30)

Country Link
JP (2) JPS58180477A (it)
KR (1) KR880002209B1 (it)
AT (1) AT386599B (it)
AU (2) AU557577B2 (it)
BE (1) BE896291A (it)
CH (2) CH655111A5 (it)
CS (2) CS250240B2 (it)
DD (2) DD219768A5 (it)
DE (1) DE3311281A1 (it)
DK (2) DK166677B1 (it)
ES (3) ES8404683A1 (it)
FR (2) FR2542741B1 (it)
GB (2) GB2117769B (it)
GR (1) GR78524B (it)
HU (2) HU196386B (it)
IE (1) IE55596B1 (it)
IL (1) IL68259A0 (it)
IT (1) IT1164633B (it)
LU (1) LU84716A1 (it)
MY (1) MY8700942A (it)
NL (1) NL8301063A (it)
NO (1) NO163055C (it)
NZ (1) NZ203726A (it)
OA (1) OA07356A (it)
PT (1) PT76459B (it)
SE (2) SE461040B (it)
SU (2) SU1419518A3 (it)
YU (1) YU44849B (it)
ZA (1) ZA832154B (it)
ZW (1) ZW7683A1 (it)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2222083A (en) * 1982-12-14 1984-06-21 Smith Kline & French Laboratories Limited Pyridine derivatives
US4593039A (en) * 1984-04-02 1986-06-03 Merck & Co., Inc. 1-aryloxy-3-(substituted aminoalkylamino)-2-propanols
US4644006A (en) * 1984-06-22 1987-02-17 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
JPH0622828B2 (ja) * 1986-06-30 1994-03-30 フアナツク株式会社 直圧式型締機構
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3018289A (en) * 1960-02-10 1962-01-23 Wyandotte Chemicals Corp Process for preparing oxamidines
GB1595291A (en) * 1976-09-21 1981-08-12 Smith Kline French Lab Pyrimidone and thiopyrimidone derivatives
FI76795C (fi) * 1979-09-04 1988-12-12 Bristol Myers Co Foerfarande foer framstaellning av nya, terapeutiskt anvaendbara 3,4-disubstituerade 1,2,5-tiadiazol-1-oxider och -1,1-dioxider samt nya mellanprodukter.
DE3175201D1 (en) * 1980-04-30 1986-10-02 Merck & Co Inc Aminothiadiazoles as gastric secretion inhibitors
AU2222083A (en) * 1982-12-14 1984-06-21 Smith Kline & French Laboratories Limited Pyridine derivatives

Also Published As

Publication number Publication date
OA07356A (fr) 1984-08-31
KR880002209B1 (ko) 1988-10-18
ZA832154B (en) 1983-12-28
ZW7683A1 (en) 1984-01-04
YU74483A (en) 1986-02-28
NO831100L (no) 1983-09-30
GB2149406A (en) 1985-06-12
CH660880A5 (de) 1987-05-29
DE3311281A1 (de) 1983-11-24
PT76459B (en) 1986-03-11
IL68259A0 (en) 1983-06-15
DK141383A (da) 1983-09-30
DD219768A5 (de) 1985-03-13
HU196386B (en) 1988-11-28
ES8505977A1 (es) 1985-06-16
AU6327286A (en) 1987-01-08
SU1419518A3 (ru) 1988-08-23
NO163055C (no) 1990-03-28
JPS58180477A (ja) 1983-10-21
IE830686L (en) 1983-09-29
ES520982A0 (es) 1984-05-16
NO163055B (no) 1989-12-18
DK81192D0 (da) 1992-06-18
ES8404683A1 (es) 1984-05-16
ES527686A0 (es) 1985-06-16
AU586037B2 (en) 1989-06-29
AU1290783A (en) 1983-10-06
KR840004095A (ko) 1984-10-06
ATA111083A (de) 1988-02-15
FR2597867A1 (fr) 1987-10-30
GB2117769A (en) 1983-10-19
PT76459A (en) 1983-04-01
LU84716A1 (fr) 1983-12-05
SE8704689L (sv) 1987-11-25
GB8432809D0 (en) 1985-02-06
DK141383D0 (da) 1983-03-28
SE8301725D0 (sv) 1983-03-28
SU1355123A3 (ru) 1987-11-23
AT386599B (de) 1988-09-12
SE464302B (sv) 1991-04-08
FR2542741A1 (fr) 1984-09-21
BE896291A (fr) 1983-09-28
MY8700942A (en) 1987-12-31
GB2149406B (en) 1986-01-02
FR2542741B1 (fr) 1989-12-08
GR78524B (it) 1984-09-27
IT8348005A0 (it) 1983-03-28
HU188742B (en) 1986-05-28
DD210909A5 (de) 1984-06-27
CS250229B2 (en) 1987-04-16
DK166677B1 (da) 1993-06-28
CS250240B2 (en) 1987-04-16
JPH0568472B2 (it) 1993-09-29
YU44849B (en) 1991-04-30
SE8301725L (sv) 1983-11-25
SE8704689D0 (sv) 1987-11-25
DK81192A (da) 1992-06-18
NZ203726A (en) 1986-05-09
IE55596B1 (en) 1990-11-21
JPH06135925A (ja) 1994-05-17
NL8301063A (nl) 1983-10-17
SE461040B (sv) 1989-12-18
ES527685A0 (es) 1985-06-16
GB2117769B (en) 1985-08-29
CH655111A5 (de) 1986-03-27
ES8505978A1 (es) 1985-06-16
FR2597867B1 (fr) 1989-12-08
GB8308518D0 (en) 1983-05-05
AU557577B2 (en) 1986-12-24

Similar Documents

Publication Publication Date Title
GB2131428B (en) Amine derivatives having histamine h2-blocking activity
DE3571618D1 (de) 2-(n-substituteguanidino)-4-hetero-arylthiazole antiulcer agents
DK435681A (da) Pyrimidonderivater med histamin h2-antagonistvirkning
AR228675A1 (es) Procedimiento para la preparacion de nuevos 2-guanidino-4-heteroariltiazoles activos como agentes antisecretores y como antagonistas h2 de la histamina
DE3374313D1 (de) Aminopyrimidinone derivatives as histamine h1-antagonists
DE3270716D1 (en) Guanidino-substituted heterocyclic derivatives having histamine h-2 antagonist activity
DK298180A (da) Histamin h2-antagonister
IT1164633B (it) 3,4-diammino-1,2,5-tiadiazoli dotati di attivita' antagonista dei recettori istaminici
IT8049815A0 (it) Composti eterociclici attivi sui recettori istaminici e procedimento per la loro preparazione
DK130984A (da) Leukotrien-antagonister
IT1183061B (it) Composti dotati di attivita'antiallergica
IT8719009A0 (it) Composti antagonisti di recettori -h2 e procedimento per la loro preparazione.
IT1176739B (it) 4(3h)-pirimidoni 2,5-disostituiti aventi attivita' antagonista dei recettori della istamina h2
IT8521217A0 (it) 3,4-diammino-1,2,5-tiadiazoli sostituiti aventi attivita'antagonista nei confronti di h2-recettori della istamina.
IT8321046A0 (it) Disposizione ad uso delle apparecchiature per l'avanzamento dei tronchi.
DK21085A (da) Leukotrienantagonister
IT8523158A0 (it) Composti eterociclici dotati di attivita' terapeutica.
ATE19775T1 (de) Aminopyrimidinonderivate verwendbar als histamin- h1-antagonisten.
KR860000739U (ko) 권사기 사도드럼의 앤티랩브러시 장치
ES266144Y (es) "nueva libreria".
AR228620A1 (es) Procedimiento para la preparacion de nuevos 2-guanidino-4-heteroariltiazoles activos como agentes antisecretores y como antagonistas h2 de la histamina
IT8423967A0 (it) Composti eterociclici dotati di attivita' terapeutica.
IT1150708B (it) Composizione farmaceutica antiulcera contenente antagonisti istaminici
KR840001621U (ko) 조립식 발코니의 체대
ES262782Y (es) "ratonera mejorada".